NPHS2 and chronic myelogenous leukemia, BCR-ABL1 positive: We showed for the first time that although the administration of RAGE-apt for 3 weeks did not affect blood pressure levels, it reduced UAE, restored podocin expression, and inhibited the increases in glomerular CML, RAGE, MR, and Rac1 levels in DOCA mice.